| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 421.00M | 1.45B | 2.23B | 579.00M | 423.00M | 200.00M |
| Gross Profit | 100.50M | 165.00M | 405.00M | 76.00M | 70.00M | 32.00M |
| EBITDA | -54.50M | 15.00M | 237.00M | -107.00M | -85.00M | -62.00M |
| Net Income | -52.00M | 1.00M | 132.00M | -87.00M | -98.00M | -76.00M |
Balance Sheet | ||||||
| Total Assets | 2.69B | 3.09B | 4.25B | 8.00B | 9.28B | 6.42B |
| Cash, Cash Equivalents and Short-Term Investments | 658.00M | 1.05B | 1.25B | 1.70B | 1.60B | 430.00M |
| Total Debt | 246.00M | 426.00M | 770.00M | 2.87B | 1.59B | 2.39B |
| Total Liabilities | 2.34B | 2.74B | 3.88B | 7.75B | 8.88B | 5.92B |
| Stockholders Equity | 300.00M | 309.00M | 309.00M | 188.00M | 285.00M | 374.00M |
Cash Flow | ||||||
| Free Cash Flow | -128.00M | 47.00M | 617.00M | 1.28B | -166.00M | -3.75B |
| Operating Cash Flow | -127.00M | 49.00M | 626.00M | 1.32B | -162.00M | -3.75B |
| Investing Cash Flow | 102.00M | 152.00M | 16.00M | -354.00M | -800.00M | 14.00M |
| Financing Cash Flow | -90.50M | -268.00M | -676.00M | -1.07B | 1.26B | 3.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$452.76M | 1.42 | 3.40% | 4.94% | 17.39% | -55.26% | |
67 Neutral | HK$530.92M | 1.25 | 5.41% | 0.98% | 9.73% | 90.98% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | HK$12.45B | 7.99 | 13.91% | 3.21% | 18.23% | 38.95% | |
60 Neutral | HK$3.27B | 3.95 | 5.16% | ― | 33.59% | -15.98% | |
52 Neutral | HK$176.40M | 23.21 | 3.87% | 3.06% | 4.82% | -71.76% | |
44 Neutral | HK$862.28M | -20.07 | -12.13% | ― | -85.44% | -172.45% |